Index
Checking point of information
at the time of initial public offering.
AI Analysis
■AI Analysis
AI statistically analyzes IPO information to identify trends.
The closer the number is to 5, the higher the rate of increase in the initial price relative to the offering price.
| popularity | scale-criteria | offering-criteria | exchange-criteria | market-condition | Business-criteria |
| 1 | 2 | 5 | 5 | 2 | 1 |
*This is an analysis of trends and does not guarantee any results.
This is not a solicitation to buy or sell stocks, nor is it investment advice.
*Please check the disclaimer for details.
■AI Analysis Chart
A group of stocks listed in the past
with similar IPO condition trends
| Name | Rate of change
(Inicial Price) |
|
| -7.9% |
|
| +10.0% |
|
| -7.0% |
|
| -8.0% |
|
| +100.1% |
|
| +46.6% |
CompanyOverview
- Company Name：J-Pharma Co. Ltd.
- Business：SLCトランスポーターをターゲットとした医薬品開発.
- The industry sector is Pharmaceutical.
- Scheduled to be listed on TSE-Growth.
- The company size is that assumed market capitalization is
approx. 128 Million JPY (excluded public offering), approx. 157 Million JPY (included public offering).
- The lead manager is ＳＢＩ.
https://www.j-pharma.com/
Initial Public Offering Memo
■ Market Cap | Offering rate | Dilution rate | lock-up information
- The company size is assumed market capitalization is
approx. 128 Million JPY (excluded new issues), approx. 157 Million JPY (included new issues).
- The total amount of new issues is 28.5 Million JPY.
- The total amount of public offering is 4.3 Million JPY.
- The dilution ratio from the new issues is 22%.
- Rate of offering is aprrox. 3%.
- The number of outstanding shares is 14,589,610 shares (excluded new issues),
17,829,610 shares (included new issues).
- The number of diluted shares for stock acquisition rights is 1,182,965 shares.
- Date of 90-day lockup release (initially scheduled) is June 22, 2026.
- Date of 180-day lockup release (initially scheduled) is September 20, 2026.
■ Book building schedule | Payment schedule
- Book building Period *1：March 6, 2026(Fri.) - March 12, 2026(Thu.)
- Priced date *2 ：March 13, 2026(Fri.)
- Payment Period *3 ：March 16, 2026(Mon.) - March 19, 2026(Thu.)
- Listing Date ：March 25, 2026(wed.)
*1:(Period for applying lottery to obtain the right to purchase)
*2:(The date when the purchase price is determined)
*3:(Period for expressing your intent to purchase and payment,if you are selected in the lottery)
■ Detail of new issue or public offering
- Unit of application：100 shares (Minimum deposit amount is 88,000 JPY.)
- Assumed issue price：920 JPY
- Tentatively price range：840 JPY - 900 JPY
- Public offering price：880 JPY
- The initial price on listed：809 JPY(-8.1％)
- Newly Issued Shares：3,240,000 shares (Domestic：2,283,200 shares ＋ Overseas：956,800 shares)
- Public offering shares：486,000 shares (Domestic：200,670,000 shares ＋ Overseas：0 shares)
- Number of domestic unit：2,029,532 Unit
- The lead manager is ＳＢＩ証券.
- The another securities companies are 大和証券/東海東京証券/東洋証券/松井証券/マネックス証券/楽天証券.
| ＳＢＩ |
大和 |
東海東京 |
東洋 |
松井 |
マネックス |
楽天 |
| Lead |
Sub |
Sub |
Sub |
Sub |
Sub |
Sub |
■ New issue or public offering - condition history
|
Update
date |
Assumed issue
price
(JPY) |
Tentatively
price range
(JPY) |
Public offering
price
(JPY) |
| Initial | 2026-02-19 | 920 JPY | | |
| Application period | 2026-03-05 | | 840 - 900 JPY | |
| Priced | 2026-03-13 | | | 880 JPY |
|
Update
date |
New issues
total shares |
New issues
(Overseas) |
PO&OA
total shares |
PO
(Domestic) |
PO
(Overseas) |
OA
(Domestic) |
OA
(Overseas) |
| Initial | 2026-02-19 | 3,240,000 | 0 | 200,670,000 | 200,184,000 | 0 | 486,000 | 0 |
| Application period | 2026-03-05 | 3,240,000 | 0 | 486,000 | 0 | 0 | 486,000 | 0 |
| Priced | 2026-03-13 | 3,240,000 | 956,800 | 486,000 | 0 | 0 | 486,000 | 0 |
※：( ) indicates the breakdown.
e.g. In the case of a PO(overseas), there are domestic and overseas allotments of the public offering, of which the overseas allotment is indicated.
PO : Public offering OA : Over allotment
